Stay updated on Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial

Sign up to get notified when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Removal of the 403 error content and the Home link indicates the study details page now loads without the forbidden error. This change restores access to the trial information and the standard page layout for viewing the study details.
    Difference
    0.5%
    Check dated 2026-09-30T22:24:03.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page shows an access-denied 403 screen, replacing the study record with a generic header/footer and removing the usual study details and related sections.
    Difference
    17%
    Check dated 2026-09-23T21:46:54.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.6 to v3.7.0, reflecting a system-wide update to the ClinicalTrials.gov page; this change does not alter the study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-09-16T21:56:52.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.6.6, indicating a minor update to the page version. This change does not modify substantive study details or participant information.
    Difference
    0.1%
    Check dated 2026-09-02T19:20:40.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, indicating a new revision of the page content.
    Difference
    0.1%
    Check dated 2026-08-12T19:23:29.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a minor update to the page's template or backend. The update does not alter the study data, eligibility criteria, or primary outcomes presented on the page.
    Difference
    0.1%
    Check dated 2026-07-22T08:15:08.000Z thumbnail image

Stay in the know with updates to Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.